Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins
- 25 April 2015
- journal article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 176 (4) , 1029-1043
Abstract
Human epidermal growth factor receptor 2 (HER2) is a member of the epidermal growth factor receptor (EGFR) family. In this study, the whole extracellular domain gene of HER2 was amplified by RT-PCR from human breast cancer cell line SK-BR-3. The genes of membrane-distal region (A) and membrane proximal region (B) of HER2 extracellular domain were amplified from the cloned template, and then inserted into the expression vector pET-28a and pET-30a, respectively. The recombinant expression vectors were transformed into Escherichia coli BL21 (DE3) cells and induced by isopropyl-b-D-thiogalactopyranoside (IPTG) for expression of proteins His-A and His-B. The expressed proteins were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot. The optimization of culture conditions led us to accomplish the recombinant protein induction with 1.0 mM IPTG at 37 °C for 8 h, and both proteins were expressed in the insoluble form. Both proteins were purified under the denaturing condition using Ni-NTA sepharose column. Balb/c mice were immunized with the purified proteins and then effectively produced polyclonal antibodies, which reached to a relatively high titer by ELISA testing and had good specificity by western blot detection. The HER2 ECD proteins His-A and His-B could be expressed in E. coli and were suitable for production of high titer antibodies against HER2 ECD.Keywords
This publication has 34 references indexed in Scilit:
- Translation efficiency is determined by both codon bias and folding energyProceedings of the National Academy of Sciences, 2010
- Purification and characterization of recombinant extracellular domain of human HER2 from Escherichia coliProtein Expression and Purification, 2007
- Effect of temperature on protein quality in bacterial inclusion bodiesFEBS Letters, 2006
- Adjuvant trastuzumab therapy for HER2-overexpressing breast cancer: What we know and what we still need to learnEuropean Journal of Cancer, 2006
- RETRACTED ARTICLE: Strategies for efficient production of heterologous proteins in Escherichia coliApplied Microbiology and Biotechnology, 2005
- An mRNA structure that controls gene expression by binding S-adenosylmethionineNature Structural & Molecular Biology, 2003
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003
- Toxicity of expanded polyglutamine‐domain proteins in Escherichia coliFEBS Letters, 1996
- Low temperature cultivation of Escherichia coli carrying a rice lipoxygenase L‐2 cDNA produces a soluble and active enzyme at a high levelFEBS Letters, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987